⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

October 1, 2024

Figure S2 from Proteomic Profiling of Serum Extracellular Vesicles Identifies Diagnostic Signatures and Therapeutic Targets in Breast Cancer

Ganfei Xu Rui Huang Reziya Wumaier Jiacheng Lyu Minjing Huang Yaya Zhang Qingjian Chen Wenting Liu Mengyu Tao Junjian Li Zhonghua Tao Bo Yu Erxiang Xu Lingfeng Wang Guoying Yu Olivier Gires Lei Zhou Wei Zhu Chen Ding Hongxia Wang

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

Proteomic characterization of BC-derived EVs, related to Figure 1

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Xu et al. (2024) studied this question.

synapsesocial.com/papers/68e56226e2b3180350efed6e https://doi.org/10.1158/0008-5472.27142996

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Figure S3 from Proteomic Profiling of Serum Extracellular Vesicles Identifies Diagnostic Signatures and Therapeutic Targets in Breast Cancer2024
2Table S2 from Proteomic Profiling of Serum Extracellular Vesicles Identifies Diagnostic Signatures and Therapeutic Targets in Breast Cancer2024
3Figure S1 from Proteomic Profiling of Serum Extracellular Vesicles Identifies Diagnostic Signatures and Therapeutic Targets in Breast Cancer2024
4Figure S5 from Proteomic Profiling of Serum Extracellular Vesicles Identifies Diagnostic Signatures and Therapeutic Targets in Breast Cancer2024
5Figure S7 from Proteomic Profiling of Serum Extracellular Vesicles Identifies Diagnostic Signatures and Therapeutic Targets in Breast Cancer2024